Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved.
First GLP-1 pill approved in the European Union for the treatment of obesity and overweight Only Wegovy® pill demonstrates 17%* ...
Read moreDetails
